A clinical trial has been listed that will compare an Ivermectin based cream made by Perrigo Company to a `reference’ Ivermectin product.
The reference product described as a “FDA approved product to treat the inflammatory lesions of rosacea” so will be Soolantra.
Perrigo might not be a well known brand – it promotes itself as;
Perrigo Company plc is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API) …The company is the world’s largest manufacturer of OTC pharmaceutical products for the store brand market and an industry leader in pharmaceutical technologies.
A competitor to Soolantra – that would be great news.
One topical ivermectin cream that is already available is Sklice, a prescription ivermectin 0.5% lotion for the treatment of head lice.
Clinical Trial NCT02795117
The purpose of this study is to compare the safety and efficacy of Perrigo’s product to an FDA approved product for the treatment of inflammatory lesions rosaceaSponsor: Perrigo CompanyPrimary Outcome Measures: Mean percent change from baseline in the inflammatory (papules and pustules) lesion count [ Time Frame: Day 84 ]Experimental: Test productActive Comparator: Reference productPlacebo Comparator: Placebo product